About
Alzheimer's Treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalGene Therapy, RNA & Peptide TherapySoutheastern U.S.
Team (8)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
101
By Phase
PHASE1: 1PHASE1/PHASE2: 2
By Status
ACTIVE_NOT_RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06921590Lead Sponsor
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
PHASE1Active, not recruiting
6 participants
Started: May 9, 2025 · Completed: Dec 31, 2025
NCT05834296Lead Sponsor
Study in Subjects With Mild-to-Moderate Alzheimer's Dementia
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Jul 5, 2023 · Completed: Mar 3, 2028
NCT05363293Lead Sponsor
Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects
PHASE1/PHASE2Completed
65 participants
Started: May 4, 2022 · Completed: May 15, 2023
Locations (1)
Headquarters
Atlanta, GA, United States
Map
Loading map...